Prevalence and knowledge of classical cardiovascular disease risk factors among patients with diabetes

• Autorzy: Dabek J. , Piotrkowicz J. , Lesniewska S. , Korzen D. , Bonek-Wytrych G.
• Języki publikacji: EN

Abstrakty

EN

Background: The prevalence of diabetes is increasing annually, and diabetes is associated with an increased risk of developing cardiovascular disease. Diabetes can significantly increase the risk of developing coronary heart disease, stroke, hypertension or ischemia of the lower limbs. Furthermore, the presence of other risk factors including; being overweight or obesity, having hypertension, having excessive stress or having low levels of physical activity also contribute to this risk as well as contributing to disease progression and mortality among patients. Aim of the study: The aim of this study was to evaluate the prevalence of risk factors for cardiovascular disease among patients with diabetes, and to assess their knowledge in this regard. Material and methods: In total, 202 patients (121 females, 81 males) aged 25–74 (mean age = 58.7) were assessed in this study, from a Polish primary care setting. Inclusion criteria included a confirmed diagnosis of diabetes and that patients had given informed consent to participate in the study. We utilized a questionnaire to assess knowledge in areas related to cardiovascular disease prevention including; physical activity, diet and lifestyle. For statistical analysis Statistica v.10.0 was used. Results: The most common cardiovascular disease risk factors included; diabetes (n = 202, 100%), obesity (n = 107; 53.0%) and stress (n = 116; 57.4%). Other contributing factors included; low physical activity (n = 179; 88.6%) and being overweight (n = 176; 87.1%). There were statistically significant differences between the number of risk factors and variables including; sex (p < 0.001), age (p < 0.001), the level of knowledge (p < 0.001) and the duration of the disease. Conclusions: Patients with diabetes had many risk factors for the development of cardiovascular disease and their knowledge of their disease was shown to be incomplete. The results indicate the need for more extensive health education in this area in order to reduce the number of risk factors and disease development.

• Wydawca: -
• Czasopismo: Medical Science Pulse
• Rocznik: 2018
• Tom: 12
• Numer: 4
• Opis fizyczny: p.9-14,fig.,ref.

Twórcy

autor

Dabek J.

• Chair and Department of Cardiology, School of Health Sciences in Katowice, Medical University of Silesia in Katowice,Katowice, Poland

autor

Piotrkowicz J.

• Katedra i Klinika Kardiologii Wydziału Nauk o Zdrowiu w Katowicach Slaski Uniwersytet Medyczny w Katowicach ,Ziolowa 45/47, 40-635 Katowice, Poland

autor

Lesniewska S.

• Chair and Department of Cardiology, School of Health Sciences in Katowice, Medical University of Silesia in Katowice,Katowice, Poland

autor

Korzen D.

• Department of Anaesthesiology and Intensive Care with Cardiac Monitoring, Leszek Giec Upper-Silesian Medical Center of the Silesian Medical University in Katowice, Katowice Poland

autor

Bonek-Wytrych G.

• Department for Health Care Supervision, Silesian Voivodeship Office in Katowice, Katowice Poland

Bibliografia

• 1. American Diabetes Association, et al. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35(1): 64–71.
• 2. Czupryniak L, Strojek A. Diabetologia 2015. Gdańsk: Via Medica; 2015. (in Polish).
• 3. WHO Consultation. Definition. Diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. Report no. 99.2. Available from URL : http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf.
• 4. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167.
• 5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35(1): 64–71.
• 6. Kara I, Nowicka TM, Bryl W. Zachowania kardioprotekcyjne u chorych na cukrzycę typu II. Forum Zaburzeń Metabolicznych 2012; 3(2): 80–84. (in Polish).
• 7. Rydén L , Grant P J, A nker SD, B erne C , Cosentino F, et a l. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EA SD. Eur Heart J 2013; 34(39): 3035–3087.
• 8. Cierniak-Piotrowska M, Marciniak G, Stańczak J. Statystyka zgonów i umieralności z powodu chorób układu krążenia. In: Strzelecki Z, Szymborski J. Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski. Warszawa: Zakład Wydawnictw Statystycznych; 2015. (in Polish).
• 9. Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD 2013; 1(1): 1–2.
• 10. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2929–2933.
• 11. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016; 34(39): 3028–3034.
• 12. Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. Jama 2015; 314(12): 1255–1263.
• 13. Teo K, Lear S, Islam S, Mony P, Dehghan M, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. Jama 2013; 309(15): 1613–1621.
• 14. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, et al. Contribution of six risk factors to achieving the 25×25 noncommunicable disease mortality reduction target: a modelling study. Lancet 2014; 384(9941): 427–437.
• 15. Sarwar N. Gao P. Seshasai SR. Diabetes mellitus. fasting blood glucose concentration. and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 22.
• 16. Preis SR, Hwang SJ, Coady S, Pencina MJ, D‘Agostino RB Sr, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study. 1950 to 2005. Circulation 2009; 119: 1728–1735.
• 17. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 2013; 127(23): e6–e245.
• 18. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16(2): 434–444.
• 19. Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Wybrane czynniki ryzyka chorób sercowo-naczyniowych u pacjentów podstawowej opieki zdrowotnej. Nadciśn Tętn 2006; 10(5): 370–376. (in Polish).
• 20. Polkowska A, Głowińska-Olszewska B, Tobiaszewska M, Bossowski A. Występowanie czynników ryzyka chorób sercowonaczyniowych u dzieci z cukrzycą typu 1 w latach 2000–2010 na terenie województwa podlaskiego. Pediatr Endocrinol Diabetes Metab 2014; 20(2): 47–54. (in Polish).
• 21. Malik VS, Popkin BM, Bray GA, Després JP, Hu FB. Sugarsweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010; 121(11): 1356–1364.
• 22. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34(7): 1481–1486.
• 23. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27(12): 2898–2904.
• 24. Look Ahead Research Group, et al. Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: four year results of the Look AHEAD trial. Arch Inter Med 2010; 170(17): 1566.
• 25. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus – present and future perspectives. Nat Rev Endocrinol 2012; 8(4): 228–236.

Identyfikatory

DOI

10.5604/01.3001.0012.7981